Q6XEC0 (BLO48_KLEPN) Klebsiella pneumoniae
Beta-lactamase OXA-48 UniProtKBInterProInteractive Modelling
265 aa; Sequence (Fasta) ;
20 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
106 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| OXA-48 with carbamylated Lys73 in complex with hydrolysed Imipenem and bromide ion competing for bi… | homo-4-mer | 100 | 3×8YF; 11×BR; 1×1BO; | |||
| OXA-48 carbapanemase, meropenem complex | homo-2-mer | 100 | 2×KE1; 5×CL; 3×CA; 2×CD; | |||
| OXA-48 in complex with Avibactam at pH 7.5 | homo-2-mer | 100 | 2×NXL; | |||
| Crystal Structure of Rationally Designed OXA-48loop18 beta-lactamase | homo-2-mer | 97.14 | 9×SO4; 9×GOL; 1×F; | |||
| Class D beta-lactamase in complex with beta-lactam antibiotic | homo-2-mer | 99.59 | 2×5R7; 5×EDO; 2×CL; 1×EPE; | |||
| Crystal structure of an OXA-48 beta-lactamase synthetic mutant | homo-2-mer | 100 | 13×GOL; 1×CL; 6×NO3; 10×EDO; 1×PEG; 1×PO4; | |||
| OXA-48-NA-1-157 inhibitor complex | homo-2-mer | 100 | 2×Y33; 3×CA; 2×CD; 4×CL; | |||
| Crystal structure of OXA-48 apoenzyme | homo-2-mer | 100 | 1×CL; 2×GOL; | |||
| Crystal structure of OXA-163 in complex with nacubactam (16 hour soak) | homo-2-mer | 100 | 2×OP0; 1×EDO; 2×GOL; 2×A1IYS; 1×CL; 1×2PE; | |||
| Crystal structure of OXA-48 in complex with nacubactam | homo-2-mer | 100 | 3×CL; 5×PGE; 5×PEG; 11×EDO; 2×OP0; 3×DMS; 3×GOL; 1×PG4; | |||
| OXA-48 carbapanemase, apo form | homo-2-mer | 100 | 4×CL; 3×CA; 2×CD; | |||
| OXA-48 with decarbamylated Lys73 in complex with avibactam at pH 8.0 | homo-2-mer | 100 | 4×1BO; 2×NXL; 4×CL; 1×GOL; | |||
| Fragments bound to the OXA-48 beta-lactamase: Compound 17 | homo-2-mer | 100 | 1×CL; 5×EDO; 2×5F3; | |||
| Crystal Structure of a Class D Carbapenemase Complexed with Hydrolyzed Imipenem | homo-2-mer | 100 | 2×HIW; 2×BR; | |||
| Crystal structure of the 19F labelled OXA-48 | homo-2-mer | 99.59 | 1×CL; 1×CA; | |||
| Crystal structure of class D Beta-lactamase OXA-48 in complex with meropenem | homo-2-mer | 100 | 2×DWZ; 8×EDO; 1×CL; | |||
| OXA-48 carbapanemase, imipenem complex | homo-2-mer | 100 | 2×IM2; 4×CL; 4×CA; 2×CD; | |||
| Crystal Structure of the OXA-48 Carbapenem-Hydrolyzing Class D beta-Lactamase in Complex with the D… | homo-2-mer | 100 | 2×QS8; 2×EDO; 1×CO2; 1×CL; | |||
| OXA-48_R250A with carbamylated Lys73 with bromide ions bound at neutral pH | homo-2-mer | 99.59 | 3×1BO; 2×BR; | |||
| Crystal structure of class D Beta-lactamase OXA-48 in complex with ertapenem | homo-2-mer | 100 | 2×2RG; 8×EDO; 1×CL; | |||
| OXA-48 with carbamylated Lys73 in complex with bicarbonate ions at neutral pH | homo-2-mer | 100 | 3×BCT; | |||
| OXA-48 in complex with Avibactam at pH 8.5 | homo-2-mer | 100 | 2×NXL; | |||
| OXA-48 in complex with FPI-1602 | homo-2-mer | 100 | 2×602; 1×CL; 2×CD; 8×CO; | |||
| Crystal Structure of a Class D Carbapenemase Complexed with Imipenem | homo-2-mer | 100 | 1×ID1; 2×BR; | |||
| OXA-48 carbapanemase, ertapenem complex | homo-2-mer | 100 | 1×1RG; 3×CL; 3×CA; 3×CD; | |||
| OXA-48_Q5. Epistasis Arises from Shifting the Rate-Limiting Step during Enzyme Evolution | homo-2-mer | 97.93 | 6×CL; 2×SO4; 2×PEG; 2×MLI; | |||
| Crystal structure of OXA-48 beta-lactamase in the complex with the inhibitor ID3 | homo-2-mer | 100 | 1×CL; 2×LKH; | |||
| Crystal structure of unbound OXA-48 | homo-2-mer | 100 | ||||
| OXA-48 in complex with FPI-1523 | homo-2-mer | 100 | 2×5VR; 1×CL; 2×CD; 7×CO; | |||
| Crystal Structure of a Class D Carbapenemase Complexed with Hydrolyzed Oxacillin | homo-2-mer | 100 | 2×GOL; 8×IOD; 1×0WO; 1×V3H; | |||
| OXA-48 carbapanemase, doripenem complex | homo-2-mer | 100 | 2×4J6; 2×O6P; 4×CL; 3×CA; 2×CD; | |||
| OXA-48_L67F_CAZ. What Doesnt Kill You Makes You Stronger: Sub-MIC Selection Drives Cryptic Evolutio… | homo-2-mer | 99.59 | 1×RYE; 3×CL; | |||
| Apo OXA-48 with fully carbamylated Lys73 at pH 7.5 | homo-2-mer | 100 | 4×1BO; | |||
| OXA-48_F72L. Epistasis Arises from Shifting the Rate-Limiting Step during Enzyme Evolution | homo-2-mer | 99.59 | 1×CL; | |||
| Crystal structure of OXA-48 beta-lactamase in the complex with the inhbitor ID2 | homo-2-mer | 100 | 1×CL; 2×LKW; | |||
| Fragments bound to the OXA-48 beta-lactamase: Compound 3 | homo-2-mer | 100 | 1×CL; 1×5F5; | |||
| Homocitrullinated beta-lactamase OXA-48 | homo-2-mer | 99.59 | 2×SO4; 1×CL; | |||
| OXA-48_P68A-AVI. Evolutionary trade-offs of OXA-48 mediated ceftazidime-avibactam resistance | homo-2-mer | 99.57 | 2×NXL; 1×CO2; 3×CL; | |||
| OXA-48 covalent complex with Avibactam inhibitor | homo-2-mer | 100.0 | 2×NXL; 1×CO2; | |||
| OXA-48_P68A-CAZ. Evolutionary trade-offs of OXA-48 mediated ceftazidime-avibactam resistance | homo-2-mer | 99.56 | 1×CTJ; 4×CL; 2×PGE; | |||
| Fragments bound to the OXA-48 beta-lactamase: Compound 1 | homo-2-mer | 100 | 2×5FL; 1×CL; | |||
| OXA-48 in complex with Avibactam at pH 6.5 | homo-2-mer | 100 | 2×NXL; | |||
| Structural basis for OXA-48 dimerization - R189A mutant | homo-2-mer | 99.59 | 1×CL; | |||
| OXA-48_Q5-CAZ. Epistasis Arises from Shifting the Rate-Limiting Step during Enzyme Evolution | homo-2-mer | 97.81 | 1×CTJ; 1×CL; | |||
| Structural basis for OXA-48 dimerization | homo-2-mer | 99.59 | ||||
| Structure of OXA-48 bound to QPX7728 at 1.80 A | homo-2-mer | 100 | 2×RM9; 4×MG; 1×CL; | |||
| OXA-48 beta-lactamase - S70A mutant | homo-2-mer | 99.58 | 1×CL; 1×1PE; 2×PGE; 2×NA; 8×PEG; 1×MPD; 1×PG4; 4×EDO; | |||
| Crystal structure of OXA-48 beta-lactamase | homo-2-mer | 100.0 | 3×EDO; | |||
| Fragments bound to the OXA-48 beta-lactamase: Compound 2 | homo-2-mer | 100 | 2×5F8; 1×CL; | |||
| OXA-48 in complex with FPI-1465 | homo-2-mer | 100 | 3×CD; 1×CL; 2×5VW; 6×CO; | |||
| OXA-48 bound by Compound 2.3 | homo-2-mer | 100 | 2×VAJ; 2×NA; 3×EDO; 1×PEG; 1×CL; | |||
| Crystal structure of OXA-48 K73A in complex with meropenem | homo-2-mer | 99.58 | 2×MER; 4×CL; 2×ZN; | |||
| OXA-48 bound by Compound 3.3 | homo-2-mer | 100 | 2×3I0; 4×EDO; 2×DMS; 2×CL; | |||
| OXa-48 beta-lactamase mutant - S70G | homo-2-mer | 99.58 | 4×CD; 2×FMT; | |||
| OXA-48 bound by inhibitor CDD-97 | homo-2-mer | 100 | 2×QHY; 2×CL; 1×EDO; | |||
| OXA-48 bound by Compound 2.2 | homo-2-mer | 100 | 2×VBV; 1×CL; | |||
| Crystal structure of OXA-48 K73A in complex with imipenem | homo-2-mer | 99.58 | 2×IM2; 4×CL; | |||
| OXA-48 bound by Compound 4.3 | homo-2-mer | 100 | 4×EDO; 2×XV7; 1×NA; 3×CL; | |||
| OXA-48 bound by Compound 3.1 | homo-2-mer | 100 | 2×BIH; 1×CL; 4×NA; 1×EDO; | |||
| OXA-48 bound to inhibitor CDD-2725 | monomer | 100 | 1×WIP; 1×BCT; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 32 | monomer | 100 | 1×X6P; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 26b | monomer | 100 | 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 8a | monomer | 100 | 1×WVV; 8×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 26a | monomer | 100 | 1×CL; 3×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 38 | monomer | 100 | 1×U3M; 3×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 21a | monomer | 100 | 1×CL; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 36 | monomer | 100 | 1×CL; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 4b | monomer | 100 | 1×IQQ; 3×EDO; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 17 | monomer | 100 | 1×GA6; 3×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 12a | monomer | 100 | 1×VM7; 1×CL; 2×EDO; 1×DMS; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 14 | monomer | 100 | 1×AV4; 1×CL; 1×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 23b | monomer | 100 | 1×CVF; 1×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 24 | monomer | 100 | 1×T7O; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 5 | monomer | 100 | 1×QKU; 1×CL; 1×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 9b | monomer | 100 | 1×EFX; 1×CL; 1×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 11b | monomer | 100 | 1×TVZ; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH SUBSTRATE IMIPENEM | monomer | 100 | 1×IM2; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 3a | monomer | 100 | 1×TI7; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 35 | monomer | 100 | 1×AVA; 1×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 3b | monomer | 100 | 1×L5D; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 4a | monomer | 100 | 1×AUV; 1×CL; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 6a | monomer | 100 | 1×EAJ; 1×CL; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 13 | monomer | 100 | 1×VBC; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 19b | monomer | 100 | 1×Z8R; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 6c | monomer | 100 | 1×U4J; 1×CL; 2×EDO; | |||
| OXA-48 bound to inhibitor CDD-2801 | monomer | 100 | 1×BCT; 1×X6Q; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 8b | monomer | 100 | 1×Q4G; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 23a | monomer | 100 | 1×QIU; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 8c | monomer | 100 | 1×S1D; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 6b | monomer | 100 | 1×XEV; | |||
| Serine Beta-Lactamase OXA-48 in Complex with MBL/SBL Inhibitor CB1 | monomer | 100 | 1×A1EG0; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 27 | monomer | 100 | 1×TVC; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 34 | monomer | 100 | 1×Q2S; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 9a | monomer | 100 | 1×Q2R; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 19a | monomer | 100 | 1×M8Q; 1×CL; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 28 | monomer | 100 | 1×Q92; 1×CL; 2×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 21b | monomer | 100 | 1×CL; 1×EDO; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 4c | monomer | 100 | 1×JSX; | |||
| Crystal Structure of OXA-48 with Hydrolyzed Imipenem | monomer | 100 | 2×HIW; 1×CL; 2×GOL; | |||
| OXA-48 carbapenemase in complex with (R)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acrylic… | monomer | 100 | 1×H9O; | |||
| OXA-48 IN COMPLEX WITH COMPOUND 40 | monomer | 100 | 1×AVM; 1×CL; | |||
| Crystal Structure of Class D Beta-lactamase OXA-48 with Meropenem | monomer | 100 | 2×CL; 1×MER; | |||
| Crystal Structure of Class D Beta-lactamase OXA-48 with Imipenem | monomer | 100 | 2×CL; 1×ID1; | |||
| Crystal Structure of Class D Beta-lactamase OXA-48 with Cefotaxime | monomer | 100 | 1×CEF; 2×CL; 1×ACT; | |||
| Crystal Structure of Class D Beta-lactamase OXA-48 with Faropenem | monomer | 100 | 1×CL; 1×DGF; | |||
| Crystal Structure of Class D Beta-lactamase OXA-48 with Cefoxitin | monomer | 100 | 1×CL; 1×1S7; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7ass.1.A | homo-2-mer | 0.91 | 1×RYE; | 99.62 | ||